Copay Assistance Strategy Reduces Financial Burdens for Plans And Patients
Innovative solution provides $0 member cost for costly specialty drugs while reducing plans’ costs
Read MoreImproving Specialty Prescribing Turnaround Time
Through secure automation, Accredo is improving the specialty prescribing journey for physicians so patients receive their medication faster.
Read MoreHow Value-based Solutions Can Improve Costs and Health Outcomes for Chronic Conditions
Over 125 million Americans suffer from chronic conditions, costing the U.S. over $3.4 trillion annually. This topic was the focus of a breakout session at Outcomes+ 2022.
Read MoreNurses Improve Health Outcomes
Whether nurses have direct interaction with patients or work in non-traditional roles, their knowledge and expertise can improve health outcomes for patients.
Read MoreWhy a home infusion strategy is more important than ever
Growing demand and new regulations have put the onus on plan sponsors to prioritize the need for a comprehensive home infusion strategy.
Read MoreSimplifying medical benefit drug management complexities
An integrated approach to managing medically billed specialty drugs is key to optimizing cost savings and clinical outcomes.
Read MoreStrategies to Encourage the Adoption of Biosimilars
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Read MoreThe Pharmacy Benefit Management Team: Helping Patients Access Affordable Prescription Drugs Safely and Efficiently
Pharmacy benefit managers (PBMs) like Express Scripts are uniquely positioned to help patients in numerous ways.
Read MoreExpress Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read MoreWhat to look for in the upcoming gene therapy pipeline
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Read More